Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector, IMCgp100 in advanced uveal melanoma in two phase 1 trials Meeting Abstract
| Authors: | Carvajal, R.; Sato, T.; Shoushtari, A. N.; Sacco, J.; Nathan, P.; Orloff, M.; Corrie, P.; Steven, N.; Evans, J.; Infante, J.; Sznol, M.; Mulatero, C.; Hamid, O.; Hernandez-Aya, L.; Little, N.; McAlpine, C.; Krige, D.; Hassan, N. J.; Patel, S.; Hulstine, A. M.; Coughlin, C. M.; Middleton, M. R. |
| Abstract Title: | Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector, IMCgp100 in advanced uveal melanoma in two phase 1 trials |
| Meeting Title: | 32nd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 5 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Nov 8-12 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2017-11-07 |
| Start Page: | 86 |
| Language: | English |
| DOI: | 10.1186/s40425-017-0289-3 |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: P208 |
